Inventor · disambiguated record
Craig Crowley
Also filed as: CROWLEY CRAIG · CROWLEY CRAIG W
6 granted patents·17 pending applications·538 citations·filing 1994–2021
89Inventor score
Top patents by PatentIndex Score
23 records- 0198US7799900B2Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2005·Granted Sep 21, 2010·103 cites·19 claims
- 0297US8562992B2Immunoglobulin variants and uses thereofADAMS CAMELLIA W·Filed 2008·Granted Oct 22, 2013·69 cites·6 claims
- 0397US5532359ARas farnesyl transferase inhibitorsGENENTECH INC·Filed 1994·Granted Jul 2, 1996·192 cites·10 claims
- 0486US9085630B2Compositions and methods for the treatment of tumor of hematopoietic originCROWLEY CRAIG·Filed 2011·Granted Jul 21, 2015·10 cites·39 claims
- 0586US5561053AMethod for selecting high-expressing host cellsGENENTECH INC·Filed 1994·Granted Oct 1, 1996·116 cites·20 claims
- 0682US5843941ARas farnesyl transferase inhibitorsGENENTECH INC·Filed 1994·Granted Dec 1, 1998·48 cites·17 claims
- 0776US2022002430A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 0865US2019071511A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 0963US2014154242A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2013·Application pending·0 cites
- 1062US2005238650A1Compositions and methods for the treatment of tumor of hematopoietic originGENENTECH INC·Filed 2004·Application pending·0 cites
- 1162US2009068178A1Compositions and Methods for the Treatment of Tumor of Hematopoietic OriginGENENTECH INC·Filed 2008·Application pending·0 cites
- 1261US2017158773A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2016·Application pending·0 cites
- 1359US2006024300A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2005·Application pending·0 cites
- 1457US2005005310A1Expression vectors and methodsGENENTECH INC·Filed 2003·Application pending·0 cites
- 1556US2017362318A1Compositions and methods for the treatment of tumor hematopoietic originGENENTECH INC·Filed 2017·Application pending·0 cites
- 1653US2009053226A1Compositions and methods for the treatment of tumor of hematopoietic originCROWLEY CRAIG·Filed 2008·Application pending·0 cites
- 1752US2007054303A1Expression Vectors and MethodsGENENTECH INC·Filed 2006·Application pending·0 cites
- 1849US2011206658A1Compositions and methods for the treatment of tumor of hematopoietic originCROWLEY CRAIG·Filed 2010·Application pending·0 cites
- 1948US2011070243A1Compositions and methods for the treatment of tumor of hematopoieticCROWLEY CRAIG·Filed 2010·Application pending·0 cites
- 2045US2007207142A1Compositions and methods for the treatment of tumor of hematopoietic originGENENTECH INC·Filed 2006·Application pending·0 cites
- 2145US2007037254A1Expression Vectors and MethodsGENENTECH INC·Filed 2006·Application pending·0 cites
- 2239US2011045005A1Compositions and methods for the treatment of tumor of hematopoietic originCROWLEY CRAIG·Filed 2010·Application pending·0 cites
- 2334US2011042260A1Compositions and methods for the treatment of tumor of hematopoietic originCROWLEY CRAIG·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Craig Crowley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →